CoChat

A Comparative Genome-Wide Transcriptome Analysis of Glucocorticoid Responder and Non-Responder Primary Human Trabecular Meshwork Cells

Open access

Published version of a preprint

The DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index.

Abstract

Aim: To investigate genes and pathways involved in differential glucocorticoid (GC) responsiveness in human trabecular meshwork (HTM) cells using RNA sequencing. Methods: Using paired human donor eyes, human organ-cultured anterior segment (HOCAS) was established in one eye to characterize GC responsiveness based on intra ocular pressure (IOP) change and, in the other eye, primary HTM cell culture was established. For RNA sequencing, total RNA extracted from GC-responder (GC-R) and non-responder (GC-NR) cells after dexamethasone (DEX) or ethanol (ETH) treatment for 7d was used. Differentially expressed genes (DEGs) were compared among five groups and validated. Results: In total, 616 and 216 genes were identified as significantly dysregulated in Group #1 and #2 (#1: ETH vs. DEX-treated GC-R; #2: ETH vs. DEX-treated GC-NR), respectively. Around 80 genes were commonly dysregulated in Group #3 (overlapping DEGs between #1 and #2), whereas 536 and 136 genes were uniquely expressed in GC-R (#4) and GC-NR HTM (#5) cells, respectively. Pathway analysis revealed that WNT signaling, drug metabolism cytochrome p450, cell adhesion, TGF-β signaling, and MAPK signaling were associated with GC responsiveness. Conclusion: This is the first study reporting distinct gene signatures and their associated pathways for GC-R and GC-NR HTM cells. WNT and MAPK signaling are potential therapeutic targets for the management of GC-induced glaucoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/genes13050882

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effect of DEX on IOP (a) The mean ± SEM of ∆IOP of DEX-treated responder and non-responder eyes were plotted over time. The basal IOP on day 0 (before DEX treatment) was set at 0 mmHg. Treatment with DEX showed a significant elevated IOP in 7/16 eyes (Mean ± SEM-mΔIOP: 13.8 ± 3.41 mmHg; response rate: 43.8%). (b) Frequency plot of IOP data. The m∆IOP of GC-R and GC-NR groups were plotted. The m∆IOP was increased after DEX treatment in GC-R eyes as compared to GC-NR eyes. Data were analyzed by unpaired 2-tailed Student’s t-test on each treatment day; * p < 0.05; ** p < 0.001.
Figure 1 Effect of DEX on IOP (a) The mean ± SEM of ∆IOP of DEX-treated responder and non-responder eyes were plotted over time. The basal IOP on day 0 (before DEX treatment) was set at 0 mmHg. Treatment with DEX showed a significant elevated IOP in 7/16 eyes (Mean ± SEM-mΔIOP: 13.8 ± 3.41 mmHg; response rate: 43.8%). (b) Frequency plot of IOP data. The m∆IOP of GC-R and GC-NR groups were plotted. The m∆IOP was increased after DEX treatment in GC-R eyes as compared to GC-NR eyes. Data were analyzed by unpaired 2-tailed Student’s t-test on each treatment day; * p < 0.05; ** p < 0.001.CC BY · PubMed Central
Figure 2 Volcano plot showing the distribution of DEGs The fold of change (log2) and p-value (-log10) of differentially expressed genes from (a) Group #1 and (b) Group #2 are represented. Red color indicates the significantly dysregulated genes with an absolute fold change >2 and p-value: <0.05. Note: Group #1: DEGs between DEX- and ETH-treated GC-R HTM cells; Group #2 DEGs between DEX- and ETH-treated GC-NR HTM cells.
Figure 2 Volcano plot showing the distribution of DEGs The fold of change (log2) and p-value (-log10) of differentially expressed genes from (a) Group #1 and (b) Group #2 are represented. Red color indicates the significantly dysregulated genes with an absolute fold change >2 and p-value: <0.05. Note: Group #1: DEGs between DEX- and ETH-treated GC-R HTM cells; Group #2 DEGs between DEX- and ETH-treated GC-NR HTM cells.CC BY · PubMed Central
Figure 3 Venn diagram showing differentially expressed gene (DEG) groupings. DEGs of three groups from RNA seq data are shown; only genes with absolute fold change >2 and significant p value < 0.05 were included in these groupings. Note: Group #1: DEGs between ETH- and DEX-treated cells of GC-R HTM cells; Group #2: DEGs between ETH- and DEX-treated cells of GC-NR HTM cells; Group #3: common genes between Group #1 and Group #2; Group #4: uniquely expressed genes in GC-R; and Group #5: uniquely expressed genes in GC-NR.
Figure 3 Venn diagram showing differentially expressed gene (DEG) groupings. DEGs of three groups from RNA seq data are shown; only genes with absolute fold change >2 and significant p value < 0.05 were included in these groupings. Note: Group #1: DEGs between ETH- and DEX-treated cells of GC-R HTM cells; Group #2: DEGs between ETH- and DEX-treated cells of GC-NR HTM cells; Group #3: common genes between Group #1 and Group #2; Group #4: uniquely expressed genes in GC-R; and Group #5: uniquely expressed genes in GC-NR.CC BY · PubMed Central
Figure 4 (A) Validation of DEGs by RT2-PCR Array. Expression profile of selected genes identified from RNA-seq and validated by RT2-Profiler PCR array is shown. Primary HTM cells were treated with 100 nM DEX or 0.1% ETH for 7 days. Total RNA was extracted, converted to cDNA, and the expression profile of selected genes were carried out by RT2 -PCR array as per the manu-acturer’s instructions (refer to the methods). Gene expressions were normalized to ACTB and ana-lyzed using the 2−ΔΔCT method followed by Log2FC calculation. (i) Expression profile of selected genes from Group #3-GC-R, (ii) Group #3-GC-NR, (iii) Group #4, and (iv) Group #5 are shown. The data are represented as mean ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001. Paired 2-tailed Student’s t test. (B) Validation of RNA sequencing findings by RT2-PCR Array. Out of 32 genes, the expression pattern identified from RNA-seq of 30 genes matched with RT2 -PCR array analysis. DEGs from (i) Group #3, (ii) Group #4, and Group #5.
Figure 4 (A) Validation of DEGs by RT2-PCR Array. Expression profile of selected genes identified from RNA-seq and validated by RT2-Profiler PCR array is shown. Primary HTM cells were treated with 100 nM DEX or 0.1% ETH for 7 days. Total RNA was extracted, converted to cDNA, and the expression profile of selected genes were carried out by RT2 -PCR array as per the manu-acturer’s instructions (refer to the methods). Gene expressions were normalized to ACTB and ana-lyzed using the 2−ΔΔCT method followed by Log2FC calculation. (i) Expression profile of selected genes from Group #3-GC-R, (ii) Group #3-GC-NR, (iii) Group #4, and (iv) Group #5 are shown. The data are represented as mean ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001. Paired 2-tailed Student’s t test. (B) Validation of RNA sequencing findings by RT2-PCR Array. Out of 32 genes, the expression pattern identified from RNA-seq of 30 genes matched with RT2 -PCR array analysis. DEGs from (i) Group #3, (ii) Group #4, and Group #5.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 9

Metadata

Authors
Kathirvel, K., Haribalaganesh, R., Krishnadas, R., Muthukkaruppan, V., Willoughby, C. E., Bharanidharan, D., & Senthilkumari, S.
Affiliations
  • Department of Ocular Pharmacology, Aravind Medical Research Foundation, Madurai 625020, Tamilnadu, India
  • Aravind Eye Hospital (IN)
  • Department of Immunology and Stem Cell Biology, Aravind Medical Research Foundation, Madurai 625020, Tamilnadu, India
  • University of Ulster (GB)
  • Department of Bioinformatics, Aravind Medical Research Foundation, Madurai 625020, Tamilnadu, India
Corresponding author
Senthilkumari, Srinivasan
Venue
Genes
Publisher
MDPI AG
Published
2022-05-15
Volume
13
Issue
5
Pages
882
ISSN
2073-4425 (ISSN-L)
OpenAlex
W4280624796
Cited by
9
References
49
Citations by year
2026: 4 · 2025: 1 · 2023: 3 · 2022: 1
FWCI
1.12
Type
journal article
Language
en
Open access
Locations
  • Genes (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Ulster University Research Portal (Ulster University) (acceptedVersion, cc-by)
Funders
Department of Biotechnology (DBT)-Wellcome Trust/India Alliance fellowship (IA/I/16/2/502694)
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
  • Health Sciences › Medicine › Ophthalmology › Ocular Disorders and Treatments
Keywords
glucocorticoid responsiveness, human trabecular meshwork cells, glucocorticoid-induced glaucoma, dexamethasone, ethanol, differentially expressed genes, Wnt signaling, MAPK signaling, TGF-beta signaling, cell adhesion, gene expression signatures, intraocular pressure
MeSH terms
Glucocorticoids, Humans, Intraocular Pressure, Trabecular Meshwork, Gene Expression Profiling, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Comparative Genome-Wide Transcriptome Analysis of Glucocorticoid Responder and Non-Responder Primary Human Trabecular Meshwork Cells. https://app.cochat.ai/papers/10.3390/genes13050882
The paper
Kathirvel, K., Haribalaganesh, R., Krishnadas, R., Muthukkaruppan, V., Willoughby, C. E., Bharanidharan, D., & Senthilkumari, S. (2022). A Comparative Genome-Wide Transcriptome Analysis of Glucocorticoid Responder and Non-Responder Primary Human Trabecular Meshwork Cells. Genes. https://doi.org/10.3390/genes13050882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.